It was reported that during stenting of an sfa occlusion, the sheath of the delivery system broke when the vascular stent was being partially released.During retraction of the deployment system through the introducer sheath, the vascular stent fractured.An additional stent was implanted to cover the fractured segment of the stent and complete the procedure successfully.No patient injury was reported.
|
Based on the lot history review the subject device complied with all manufacturing specifications leading to final device release.In reviewing manufacturing and quality records, no relevant manufacturing process changes were implemented that could have led to the event reported.No manufacturing anomalies or deviations, which may have caused or contributed to the event reported, have been identified.Based on the evaluation of the sample returned it could be confirmed that the deployment mechanism had been actively used until breakage of a force transmitting component occurred when the stent was partially released.The breakage of an additional component in the proximal section of the device was assessed to be a consequence of the increased force during the removal difficulties.Increased friction in the distal section of the delivery system was considered as reason for increased release force and subsequent breakage of the force transmitting component.No indication was found for manufacturing related issues.Potential factors that could have led or contributed to reported event have been evaluated.Therefore, previous investigations of similar complaints have been reviewed.The reported event may be related to difficult anatomical conditions as tortuous or calcified vessels may lead to increased friction.A not performed predilation of the lesion could be also a contributing factor for the reported event.Furthermore, the event reported may be use related as rough handling may lead to friction increase.Based on the information available and the evaluation of the sample returned, a definite root cause for the event reported could not be determined.In reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risks.The ifu states: "do not constrict the delivery system during stent deployment.If excessive force is felt during stent deployment, do not force the stent system.Remove the stent system and replace with a new unit." and "predilation of the lesion should be performed using standard techniques.".In this case no predilation was performed.Evaluation completed.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
|